The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there is this form so partial Li industry is is characterized or classified in you know how it's been defined historically and there's called familial partial liist 1 two 3 four and Beyond fld1 doesn't have a monogenic cause it's by far in a way going to be the most common
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
but there's not an agreed upon way to make that diagnosis today which I think is a major problem and it's going to need to be addressed